Summary: Nyxoah SA presented additional data from its DREAM US study on the Genio neurostimulation system for treating obstructive sleep apnea (OSA) at the 2024 International Surgical Sleep Society (ISSS) Educational Update, which showed that Genio’s bilateral stimulation … [Read more...]
Lumryz Reduces Narcolepsy Symptoms, Regardless of Use of Alerting Drugs
Summary: A post-hoc analysis of the phase 3 REST-ON trial demonstrated that Lumryz (sodium oxybate) improves narcolepsy symptoms, including wakefulness, cataplexy episodes, and daytime sleepiness, regardless of whether patients were also using alerting medications. Both … [Read more...]
Vibrotactile Sleep Patch Reduces Insomnia-Related Symptoms
Summary: A study to be presented at the Sleep Europe Congress in Seville, Spain, highlights the effectiveness of a non-pharmacological, vibrotactile trigger technology (VTT)-embedded sleep patch in improving sleep quality, duration, and reducing insomnia-related symptoms. The … [Read more...]
SleepScore Labs’ App Improves Sleep, Reduces Stress in Study
Summary: SleepScore Labs introduced positive outcomes from a randomized controlled demo of its digital slumber advancement plan, the Dein Schlaf Dein Tag application. The analyze, involving 412 people today with very poor sleep, found considerable enhancements in rest high … [Read more...]
AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial
Summary: In the SYMPHONY stage 3 trial, Axsome Therapeutics’ AXS-12 considerably lowered weekly cataplexy assaults and improved indications of narcolepsy, which include extreme daytime sleepiness, cognitive operate, and over-all ailment severity, when compared to placebo. The … [Read more...]
Genio Neurostimulator Reduces Sleep Apnea Severity
Nyxoah SAs Desire US pivotal analyze, made to assist the advertising and marketing authorization of the Genio hypoglossal nerve stimulation procedure for obstructive sleep apnea in the United States, achieved a statistically substantial reduction in the co-key endpoints of … [Read more...]
Investigational Nasal Spray Modestly Reduces OSA Severity | Sleep Review
Australian researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of obstructive sleep apnea (OSA) in people and lower their blood pressure. The research is published in The Journal of Heart and Circulatory Physiology. The study aimed to … [Read more...]
Sublingual Treatment Aids Sleep and Reduces PTSD in Veterans
A phase 3 study found that bedtime sublingual cyclobenzaprine (TNX-102 SL), an investigational drug being developed by Tonix Pharmaceuticals Holding Corp, is well-tolerated and showed nominal improvement in post-traumatic stress disorder (PTSD) severity and sleep quality measures … [Read more...]